|
Delayed
Nasdaq Tallinn
14:30:00 28/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 18.90 EUR | -0.53% |
|
-0.53% | -32.50% |
| 1 day | -0.53% | ||
| 1 week | -0.53% | ||
| Current month | -1.56% | ||
| 1 month | -2.58% | ||
| 3 months | -15.62% | ||
| 6 months | -26.17% | ||
| Current year | -32.50% |
| 1 week | 18 |  | 19 |
| 1 month | 10.2 | | 19.4 |
| Current year | 10.2 | | 28 |
| 1 year | 10.2 | | 30.8 |
| 3 years | 9.7 | | 32.6 |
| 5 years | 5 | | 32.6 |
| 10 years | 5 | | 32.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | 52 | 31/12/2014 | |
Liina Kervemann
DFI | Director of Finance/CFO | - | - |
Erik Berlin
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Karita Sall
BRD | Director/Board Member | 52 | - |
Yoann John Ricau
BRD | Director/Board Member | 51 | - |
Martin Wilson
BRD | Director/Board Member | 49 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.53% | -0.53% | -28.95% | +82.61% | 36.98M | |
| +3.38% | +3.92% | +26.96% | +78.55% | 48.2B | |
| +0.66% | +0.33% | +54.40% | +120.88% | 39.97B | |
| -2.49% | +5.21% | +17.18% | +85.56% | 12.43B | |
| -1.00% | -2.00% | -11.21% | +12.05% | 12.03B | |
| +0.19% | 0.00% | +29.35% | +150.00% | 9.35B | |
| -1.50% | -1.28% | +25.69% | +49.12% | 7.75B | |
| -1.39% | +3.74% | +28.71% | +223.40% | 7.43B | |
| -0.26% | +0.27% | +43.89% | -11.26% | 7.22B | |
| -0.53% | -1.53% | -36.09% | +17.02% | 5.3B | |
| Average | -0.35% | +2.09% | +14.99% | +80.79% | 14.97B | |
| Weighted average by Cap. | +0.81% | +1.42% | +29.15% | +88.70% |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | €18.90 | -0.53% | 14 |
| 27/08/26 | €19.00 | +0.53% | 21 |
| 26/08/26 | €18.90 | +5.00% | 1 |
| 24/08/26 | €18.00 | -5.26% | 54 |
- Stock Market
- Stocks
- MOLNRIPO Stock
Select your edition
All financial news and data tailored to specific country editions
